bioRxivCancer Biology
Mimicking tumor cell heterogeneity of colorectal cancer in a patient-derived organoid-fibroblast model
V. S. Atanasova, C. d. J. Cardona, V. Hejret, A. Tiefenbacher, L. Tran, C. Binder, T. Mair, J. Kabiljo, J. Clement, K. Woeran, B. Neudert, M. Hengstschlaeger, M. Mitterhauser, L. Muellauer, B. Tichy, M. Bergmann, G. Schweikert, M. Hartl, H. Dolznig, G. Egger
Abstract
Patient-derived organoid (PDO) cancer models are generated from epithelial tumor cells. Although they reflect the molecular tumor characteristics, they lack the complexity of the tumor microenvironment, which is a key driver of tumorigenesis and therapy response. Here, we present a colorectal cancer (CRC) organoid model that incorporates epithelial cells and stromal fibroblasts from the same patient. Molecular characterization of primary cancer associated fibroblasts (CAFs) and matched normal fibroblasts (NF) revealed proteomic, secretome and gene expression differences in pathways associated with tumor related fibroblast function. Further, CAFs retained higher motility compared to NFs in vitro. Importantly, both CAFs and NFs supported cancer cell proliferation in 3D co-cultures, without the addition of classical niche factors. PDOs grown together with fibroblasts displayed a larger cellular heterogeneity of tumor cells compared to mono-cultures, and closely resembled the in vivo tumor morphology. This was also confirmed by the calculation of cellular proportions of epithelial cell subtypes in organoid mono-versus co-cultures, which were inferred through bioinformatics deconvolution of bulk RNA sequencing data using published single cell RNA sequencing datasets from CRC tissues. Additionally, we observed a mutual crosstalk between tumor cells and fibroblasts in the co-cultures. This was manifested by majorly deregulated pathways such as cell-cell communication and extracellular matrix remodeling in the organoids. For the fibroblasts, we observed enhanced expression of tumor induced marker genes and cytokines characteristic for myo- and immunogenic fibroblasts. This model will be vital as a physiological personalized tumor model to study disease mechanisms and therapy response in CRC. One Sentence SummaryPatient matched fibroblasts support tumor organoid growth in 3D co-culture and maintain intratumoral cellular heterogeneity and histo-morphology.
- organism: human
- assay: bulk RNA-seq
- assay: proteomics
- research focus: cell type annotation
- research focus: clustering
- research focus: cell-cell communication
- approach: biophysical modeling
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A colorectal cancer organoid-CAF co-culture chip for drug screening and personalized therapy
Rongrong Xiao, Zhijie Wang, … Xiaoni Ai·bioRxiv·Jun 19, 2026
- Dissection and reconstruction of the colorectal cancer tumor microenvironment
N. Broguiere, L. F. Lorenzo-Martin, … M. P. Lutolf·bioRxiv·Nov 1, 2023
- Modular engineered colorectal tumor microenvironments for immuno-oncology research and drug development
Adrian M. Filip, Barbora Lavickova, … Nikolche Gjorevski·bioRxiv·Sep 23, 2026
- Multi-omics analyses of single cell-derived colorectal cancer organoids reveal intratumor heterogeneity and immune response diversity
- Recapitulating Patient-to-Patient Colorectal Cancer Tumor Heterogeneity Using Patient-Derived Xenograft Cells in an Engineered Tissue Model
Iman Hassani, Benjamin Anbiah, … Elizabeth A. Lipke·Acta BiomaterialiaPeer-reviewed·Feb 27, 2026
- Patient-Derived Tumor Organoid and Fibroblast Assembloid Models for interrogation of the tumor microenvironment in Esophageal Adenocarcinoma
B. P. Sharpe, L. A. Nazlamova, … T. J. Underwood·bioRxiv·Jan 2, 2024